Clinical Trial: A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED
Study Status: Completed
Recruit Status: RECRUITING
Condition: Persistent Corneal Epithelial Defect
Study Type: INTERVENTIONAL
Official Title: A Randomized, Multicenter, Double-Masked, Vehicle-Controlled Phase 2/3 Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With Persistent Corneal Epithe
Brief Summary:
This study is to evaluate the safety and efficacy of NEXAGON® (lufepirsen ophthalmic gel) (NEXAGON) in subjects with persistent corneal epithelial defects (PCED).The objectives of the study are to evaluate the safety and efficacy of NEXAGON in this population.
Read more